Epizyme reported $32.79M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 14M
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Amarin AMRN:US 102.96M 4.24M
Amgen AMGN:US $ 1.31B 79M
Avrobio Inc AVRO:US 9.58M 746K
Biogen BIIB:US $ 654.1M 16.8M
Bluebird Bio BLUE:US $ 68.28M 10.3M
Cerulean Pharma CERU:US $ 2.24M 413.69K
Daiichi Sankyo 4568:JP 84.5B 5.38B
Eisai 4523:JP 79.76B 5.03B
Epizyme EPZM:US $ 32.79M 1.1M
Exelixis EXEL:US $ 101.56M 3.06M
Gilead Sciences GILD:US $ 1.18B 173M
GlaxoSmithKline GSK:LN 2.5B 6M
Glaxosmithkline GSK:US 2.5B 6M
Karyopharm Therapeutics KPTI:US $ 35.1M 1.43M
Macrogenics MGNX:US $ 17.16M 1.93M
Merk MRK:US $ 2.27B 9M
Mirati Therapeutics MRTX:US $ 35.18M 5.57M
Novartis NOVN:VX 3.6B 109M
Novartis NVS:US 3.6B 109M
Pfizer PFE:US $ 2.73B 61M
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Seattle Genetics SGEN:US $ 180.28M 15.15M
Spectrum Pharmaceuticals SPPI:US $ 12.24M 2.71M
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
Xencor XNCR:US $ 10.37M 1.51M